Pyruvate inhibits the chronic damage which ensues after ischemia/reperfusion injury of kidneys

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 1033-

  Cicalese, L ^a   Yacoub, W ^a   Subbotin, V ^a   Kuddus, R ^a   Fung, J J ^a   Stanko, R ^a   Rao, A S ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CREATININE; INTERCELLULAR ADHESION MOLECULE 1; PYRUVIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; GLOMERULOSCLEROSIS; INFLAMMATORY INFILTRATE; KIDNEY ALLOGRAFT; KIDNEY ISCHEMIA; KIDNEY NECROSIS; KIDNEY PRESERVATION; MACROPHAGE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ISCHEMIA; KIDNEY; MALE; PYRUVIC ACID; RATS; RATS, INBRED LEW; REPERFUSION INJURY;

EID: 0344267773     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01891-0     Document Type: Conference Paper

References (4)

1. Alberti K.G. Clin Pathol Suppl. 11:1977;14.
2. Cicalese L., Iyengar A., Subbotin V., et al. Transplant Proc. 29:1997;704.
3. Cicalese L., Le K., Schraut W., et al. Am J Surg. 171:1996;97.
4. Cicalese L., Rastellini C., Rao A.S., et al. Transplant Proc. 28:1996;2611.